Current Ratio of Inmune Bio, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Inmune Bio, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Inmune Bio, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 355%, a 63% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Inmune Bio, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 355% +137% +63% 30 Sep 2025
Q2 2025 308% +77% +33% 30 Jun 2025
Q1 2025 261% -4.1% -1.5% 31 Mar 2025
Q4 2024 231% -116% -33% 31 Dec 2024
Q3 2024 218% -234% -52% 30 Sep 2024
Q2 2024 231% -354% -61% 30 Jun 2024
Q1 2024 265% -586% -69% 31 Mar 2024
Q4 2023 347% -849% -71% 31 Dec 2023
Q3 2023 452% -1319% -74% 30 Sep 2023
Q2 2023 585% -1602% -73% 30 Jun 2023
Q1 2023 852% -1064% -56% 31 Mar 2023
Q4 2022 1196% -663% -36% 31 Dec 2022
Q3 2022 1771% +2.2% +0.12% 30 Sep 2022
Q2 2022 2188% +488% +29% 30 Jun 2022
Q1 2022 1915% +329% +21% 31 Mar 2022
Q4 2021 1859% +722% +64% 31 Dec 2021
Q3 2021 1769% +721% +69% 30 Sep 2021
Q2 2021 1700% +861% +103% 30 Jun 2021
Q1 2021 1586% +384% +32% 31 Mar 2021
Q4 2020 1136% 31 Dec 2020
Q3 2020 1048% 30 Sep 2020
Q2 2020 839% 30 Jun 2020
Q1 2020 1202% 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.